Brokerages Set Mylan (MYL) PT at $44.99


Mylan has been given an average recommendation of "Buy" by the twenty-three ratings firms that are covering the company, MarketBeat.com reports. Ten investment analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company.



from Biotech News